Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C12 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Saturday 04/22/17
10:30 AM - 12:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­
Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic
Event Timeline
10:30 AM - 10:35 AM Luncheon Introduction
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­
10:35 AM - 11:25 AM Speaker What's in the Diagnosis: Seropositive, MuSK, and Seronegative Myasthenia Gravis
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­
11:25 AM - 12:15 PM Speaker Treatment of Autoimmune Myasthenia Gravis: Evidence-based and New Developments
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­
12:15 PM - 12:30 PM Q&A Questions and Answers
Faculty Disclosures
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­ Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.